- Home
- CLB vs MDXG Comparison
CLB vs MDXG Comparison
Compare CLB & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLB
- MDXG
- Stock Information
- Founded
- CLB 1936
- MDXG 2006
- Country
- CLB United States
- MDXG United States
- Employees
- CLB N/A
- MDXG N/A
- Industry
- CLB
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- CLB
- MDXG Health Care
- Exchange
- CLB Nasdaq
- MDXG Nasdaq
- Market Cap
- CLB 951.4M
- MDXG 1.1B
- IPO Year
- CLB 1995
- MDXG N/A
- Fundamental
- Price
- CLB $19.50
- MDXG $7.46
- Analyst Decision
- CLB Sell
- MDXG Strong Buy
- Analyst Count
- CLB 4
- MDXG 5
- Target Price
- CLB $17.00
- MDXG $12.00
- AVG Volume (30 Days)
- CLB 344.3K
- MDXG 1.0M
- Earning Date
- CLB 10-23-2024
- MDXG 10-30-2024
- Dividend Yield
- CLB 0.20%
- MDXG N/A
- EPS Growth
- CLB N/A
- MDXG N/A
- EPS
- CLB 0.54
- MDXG 0.52
- Revenue
- CLB $522,821,000.00
- MDXG $342,804,000.00
- Revenue This Year
- CLB $4.59
- MDXG $9.56
- Revenue Next Year
- CLB $5.11
- MDXG $9.19
- P/E Ratio
- CLB $36.15
- MDXG $18.44
- Revenue Growth
- CLB 2.68
- MDXG 10.93
- 52 Week Low
- CLB $13.82
- MDXG $5.47
- 52 Week High
- CLB $25.13
- MDXG $9.48
- Technical
- Relative Strength Index (RSI)
- CLB 49.03
- MDXG 73.10
- Support Level
- CLB $20.41
- MDXG $5.69
- Resistance Level
- CLB $21.65
- MDXG $7.67
- Average True Range (ATR)
- CLB 0.73
- MDXG 0.30
- MACD
- CLB -0.01
- MDXG 0.15
- Stochastic Oscillator
- CLB 24.45
- MDXG 89.66
About CLB Core Laboratories Inc.
Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.